X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24160) 24160
Book Review (2729) 2729
Publication (1548) 1548
Newsletter (905) 905
Magazine Article (144) 144
Newspaper Article (46) 46
Book Chapter (41) 41
Conference Proceeding (41) 41
Transcript (34) 34
Book / eBook (16) 16
Dissertation (6) 6
Trade Publication Article (4) 4
Reference (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21794) 21794
humans (19804) 19804
staphylococcal infections - drug therapy (14319) 14319
male (10141) 10141
female (9622) 9622
anti-bacterial agents - therapeutic use (7509) 7509
staphylococcal infections - microbiology (7100) 7100
staphylococcus aureus (6116) 6116
adult (5928) 5928
middle aged (5824) 5824
staphylococcus aureus - drug effects (5065) 5065
animals (4937) 4937
aged (4580) 4580
infectious diseases (4454) 4454
microbiology (4380) 4380
microbial sensitivity tests (3920) 3920
anti-bacterial agents - pharmacology (3638) 3638
staphylococcal infections (3584) 3584
methicillin resistance (3356) 3356
infections (2944) 2944
staphylococcal infections - epidemiology (2935) 2935
staphylococcus aureus - isolation & purification (2922) 2922
adolescent (2865) 2865
abridged index medicus (2846) 2846
antibiotics (2809) 2809
child (2730) 2730
staphylococcal infections - diagnosis (2669) 2669
health aspects (2656) 2656
pharmacology & pharmacy (2554) 2554
treatment outcome (2420) 2420
anti-bacterial agents - administration & dosage (2127) 2127
drug resistance in microorganisms (2110) 2110
infection (2108) 2108
risk factors (2061) 2061
methicillin-resistant staphylococcus aureus - drug effects (2045) 2045
retrospective studies (2018) 2018
staphylococcus aureus infections (1996) 1996
staphylococcal infections - complications (1979) 1979
vancomycin (1971) 1971
methicillin-resistant staphylococcus aureus - isolation & purification (1885) 1885
child, preschool (1872) 1872
infant (1830) 1830
mice (1823) 1823
methicillin-resistant staphylococcus aureus (1763) 1763
staphylococcus infections (1742) 1742
research (1706) 1706
vancomycin - therapeutic use (1690) 1690
aged, 80 and over (1687) 1687
surgery (1675) 1675
staphylococcal infections - etiology (1674) 1674
mrsa (1629) 1629
bacteremia (1550) 1550
staphylococcal infections - prevention & control (1518) 1518
drug resistance (1517) 1517
bacteria (1465) 1465
immunology (1403) 1403
epidemiology (1390) 1390
analysis (1298) 1298
care and treatment (1296) 1296
infant, newborn (1271) 1271
drug therapy (1269) 1269
medicine, general & internal (1257) 1257
prevalence (1247) 1247
cross infection - microbiology (1218) 1218
streptococcal infections - drug therapy (1213) 1213
drug resistance, microbial (1205) 1205
endocarditis, bacterial - drug therapy (1134) 1134
nosocomial infections (1131) 1131
mortality (1113) 1113
staphylococcus - drug effects (1113) 1113
drug therapy, combination (1112) 1112
drug resistance, bacterial (1070) 1070
bacteremia - microbiology (1069) 1069
pediatrics (1066) 1066
time factors (1066) 1066
bacteremia - drug therapy (1062) 1062
cross infection - drug therapy (1062) 1062
hospitals (1051) 1051
staphylococcus aureus - genetics (1011) 1011
therapy (997) 997
antibacterial agents (989) 989
endocarditis (986) 986
disease models, animal (982) 982
prospective studies (981) 981
staphylococcal infections - therapy (969) 969
medical research (960) 960
diagnosis (957) 957
resistant staphylococcus-aureus (929) 929
staphylococcal skin infections - drug therapy (912) 912
methicillin-resistant (903) 903
children (901) 901
young adult (896) 896
cross infection - epidemiology (892) 892
cross infection (884) 884
skin (865) 865
vancomycin - pharmacology (864) 864
management (856) 856
strains (851) 851
pneumonia (847) 847
community-acquired infections - microbiology (840) 840
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21775) 21775
Russian (674) 674
French (624) 624
German (599) 599
Japanese (454) 454
Spanish (365) 365
Italian (170) 170
Polish (139) 139
Dutch (73) 73
Chinese (70) 70
Danish (64) 64
Romanian (40) 40
Turkish (39) 39
Czech (38) 38
Norwegian (35) 35
Ukrainian (32) 32
Portuguese (29) 29
Swedish (25) 25
Hungarian (19) 19
Hebrew (18) 18
Finnish (15) 15
Croatian (12) 12
Serbian (7) 7
Bulgarian (6) 6
Korean (4) 4
Lithuanian (3) 3
Slovak (3) 3
Icelandic (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Infectious Diseases, ISSN 0022-1899, 2014, Volume 210, Issue 9, pp. 1357 - 1366
Background. Limitations in treatment of biofilm-associated bacterial infections are often due to subpopulation of persistent bacteria (persisters) tolerant to... 
aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | TOLERANCE | SUSCEPTIBILITY | MICROBIOLOGY | IMMUNOLOGY | ANTIBIOTIC-LOCK THERAPY | GENTAMICIN | PSEUDOMONAS-AERUGINOSA | L-ARGININE | GROWTH | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Aminoglycosides | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
Nature, ISSN 0028-0836, 04/2012, Volume 484, Issue 7395, pp. 524 - 528
Underlying mechanisms for how bacterial infections contribute to active resolution of acute inflammation are unknown(1-4). Here, we performed exudate leukocyte... 
RESPONSES | PHAGOCYTOSIS | INHIBITION | INFLAMMATION | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | RESOLUTION | INNATE | ACUTE LUNG INJURY | MICE | ASPIRIN | Hypothermia - prevention & control | Escherichia coli - drug effects | Humans | Male | Anti-Bacterial Agents - therapeutic use | Peritonitis - microbiology | Vancomycin - pharmacology | Staphylococcal Infections - microbiology | Macrophages - immunology | Staphylococcal Infections - metabolism | Escherichia coli Infections - drug therapy | Skin Diseases - microbiology | Staphylococcal Infections - drug therapy | Microbial Viability - drug effects | Skin Diseases - metabolism | Mice, Inbred C57BL | Peritonitis - metabolism | Neutrophils - immunology | Escherichia coli - immunology | Escherichia coli Infections - microbiology | Skin Diseases - drug therapy | Escherichia coli Infections - metabolism | Animals | Vancomycin - therapeutic use | Staphylococcus aureus - immunology | Anti-Bacterial Agents - pharmacology | Mice | Peritonitis - drug therapy | Staphylococcus aureus - drug effects | Phagocytosis | Docosahexaenoic Acids - metabolism | Escherichia coli | Staphylococcus aureus infections | Cross infection | Nosocomial infections | Ciprofloxacin | Health aspects | Staphylococcus aureus | Enzymes | Immunization | Bacterial infections | Microbiology | Antibiotics | E coli | Infections | Skin | Index Medicus | Infectious Medicine | Infektionsmedicin
Journal Article
Nature, ISSN 0028-0836, 11/2015, Volume 527, Issue 7578, pp. 323 - 328
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections. The nasopharynx of infants is a major... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Nature, ISSN 0028-0836, 2013, Volume 503, Issue 7476, pp. 365 - 370
Journal Article
Annals of Emergency Medicine, ISSN 0196-0644, 2008, Volume 51, Issue 3, pp. 291 - 298
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
The proportion of antimicrobial resistance (AMR) among the ESKAPE and Escherichia coli (ESKAPEEc) pathogens causing bloodstream infection (BSI) increased... 
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | MORTALITY | INFECTIOUS DISEASES | MULTICENTER | MICROBIOLOGY | THERAPY | PREDICTORS | DISSEMINATION | ENTEROBACTERIACEAE | PATHOGENS | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 02/2011, Volume 52, Issue 3, pp. e18 - e55
Journal Article